What Is the Clinical Value Associated with Defining Additional Disease-Specific ‘Prognostic Indicators'?

Publisher： Karger

E-ISSN： 1423-0232|90|2|57-58

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.2, 2016-0, pp. : 57-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of acute cystitis in Hungary: comparison with national guidelines and with disease-specific quality indicators

By Juhasz Zoltan   Benko Ria   Matuz Maria   Viola Reka   Soos Gyongyver   Hajdu Edit  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 8, 2013-08 ,pp. : 612-615

Informa Healthcare

Access to resources Recommend Favorite

Psychometric properties of the German version of the Diabetes Eating Problem Survey–Revised: additional benefit of disease‐specific screening in adolescents with Type 1 diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1641-1647

John Wiley & Sons Inc

Access to resources Recommend Favorite

What do leaders of disease-specific advocacy organizations know about pharmacogenomics and biomarkers, anyway?

By Terry Sharon F  

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 171-181

Future Medicine

Access to resources Recommend Favorite

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

By  

Cardiology, Vol. 132, Iss. 1, 2015-0 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Change to Disease-Specific Certification Eligibility

By  

JCAH Perspectives, Vol. 29, Iss. 8, 2009-08 ,pp. : 3-3

Joint Commission Resources

Access to resources Recommend Favorite